These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 35349176

  • 1. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M, Bresnahan R, Marson AG.
    Cochrane Database Syst Rev; 2022 Mar 29; 3(3):CD005612. PubMed ID: 35349176
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
    Panebianco M, Bresnahan R, Marson AG.
    Cochrane Database Syst Rev; 2023 Dec 11; 12(12):CD001909. PubMed ID: 38078494
    [Abstract] [Full Text] [Related]

  • 7. Gabapentin add-on treatment for drug-resistant focal epilepsy.
    Panebianco M, Al-Bachari S, Weston J, Hutton JL, Marson AG.
    Cochrane Database Syst Rev; 2018 Oct 24; 10(10):CD001415. PubMed ID: 30357813
    [Abstract] [Full Text] [Related]

  • 8. Lacosamide add-on therapy for focal epilepsy.
    Babar RK, Bresnahan R, Gillespie CS, Michael BD.
    Cochrane Database Syst Rev; 2021 May 17; 5(5):CD008841. PubMed ID: 33998660
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rufinamide add-on therapy for refractory epilepsy.
    Panebianco M, Prabhakar H, Marson AG.
    Cochrane Database Syst Rev; 2018 Apr 25; 4(4):CD011772. PubMed ID: 29691835
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Zonisamide add-on therapy for focal epilepsy.
    Brigo F, Lattanzi S, Igwe SC, Behzadifar M, Bragazzi NL.
    Cochrane Database Syst Rev; 2020 Jul 24; 7(7):CD001416. PubMed ID: 32715463
    [Abstract] [Full Text] [Related]

  • 15. Pregabalin add-on for drug-resistant partial epilepsy.
    Pulman J, Hemming K, Marson AG.
    Cochrane Database Syst Rev; 2014 Mar 12; (3):CD005612. PubMed ID: 24623260
    [Abstract] [Full Text] [Related]

  • 16. Eslicarbazepine acetate add-on therapy for drug-resistant focal epilepsy.
    Chang XC, Yuan H, Wang Y, Xu HQ, Hong WK, Zheng RY.
    Cochrane Database Syst Rev; 2021 Jun 22; 6(6):CD008907. PubMed ID: 34155624
    [Abstract] [Full Text] [Related]

  • 17. Vigabatrin add-on therapy for drug-resistant focal epilepsy.
    Bresnahan R, Gianatsi M, Maguire MJ, Tudur Smith C, Marson AG.
    Cochrane Database Syst Rev; 2020 Jul 30; 7(7):CD007302. PubMed ID: 32730657
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunomodulatory interventions for focal epilepsy.
    Panebianco M, Walker L, Marson AG.
    Cochrane Database Syst Rev; 2023 Oct 16; 10(10):CD009945. PubMed ID: 37842826
    [Abstract] [Full Text] [Related]

  • 20. Oxcarbazepine add-on for drug-resistant focal epilepsy.
    Bresnahan R, Atim-Oluk M, Marson AG.
    Cochrane Database Syst Rev; 2020 Mar 04; 3(3):CD012433. PubMed ID: 32129501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.